Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Combining tuberculin skin test with follow-on interferon gamma release assay markedly improves screening of household contacts.

Thorax·2025
Same author

Ambient PM<sub>2.5</sub> exposure and tuberculosis reactivation: a cross-sectional study in an intermediate burden city.

Epidemiology and infection·2025
Same author

Assessment of the Psychometric Properties of the Mask Usability Scale: A Measure of the Perceived Usability of N95 Respirators Among Healthcare Students and Staff.

Journal of advanced nursing·2024
Same author

No increased risk of tuberculosis-related immune reconstitution inflammatory syndrome with integrase inhibitor-based antiretroviral therapy in people with HIV with profound immunosuppression.

HIV medicine·2024
Same author

Association of smoking cessation with airflow obstruction in workers with silicosis: A cohort study.

PloS one·2024
Same author

Use of spirometry to detect airflow obstruction.

Respirology (Carlton, Vic.)·2024
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: May 22, 2026

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
10:45

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

La silicosis es la silicosis.

Chi Chiu Leung1, Ignatius Tak Sun Yu, Weihong Chen

  • 1Tuberculosis and Chest Service, Centre for Health Protection, Department of Health, Hong Kong, China. cc_leung@dh.gov.hk

Lancet (London, England)
|April 27, 2012
PubMed
Resumen
Este resumen es generado por máquina.

La silicosis, una enfermedad pulmonar fibrótica causada por la inhalación de polvo de sílice, causa un deterioro progresivo de la función pulmonar. Si bien no existe cura, las estrategias de manejo mejoran la calidad de vida y retrasan la progresión de la enfermedad.

Más Videos Relacionados

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
05:03

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

Videos de Experimentos Relacionados

Last Updated: May 22, 2026

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
10:45

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
05:03

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

Área de la Ciencia:

  • Salud ocupacional y salud en el trabajo.
  • Medicina Pulmonar La medicina pulmonar es el tratamiento de las enfermedades pulmonares.
  • Toxicología Toxicología.

Sus antecedentes:

  • La silicosis es una enfermedad pulmonar fibrótica grave causada por la inhalación de sílice cristalina.
  • La exposición ocupacional al polvo de sílice es frecuente en numerosas industrias.
  • La inhalación de sílice desencadena la inflamación pulmonar y la fibrosis a través de la activación del inflamatorio.

Objetivo del estudio:

  • Para resumir la patogénesis, el diagnóstico y el manejo de la silicosis.
  • Para resaltar la asociación de la exposición a sílice con otras enfermedades pulmonares graves.
  • Hacer hincapié en la necesidad de un mejor reconocimiento y control de los peligros, especialmente en las naciones en desarrollo.

Principales métodos:

  • Revisión de la literatura existente sobre la patogénesis de la silicosis.
  • Análisis de los criterios de diagnóstico, incluidos los antecedentes profesionales y los hallazgos radiológicos.
  • Examen de las estrategias de gestión actuales y los riesgos asociados.

Principales resultados:

  • La inhalación de sílice conduce al daño lisosomal y la activación del inflamatorio NALP3, causando inflamación pulmonar y fibrosis.
  • El deterioro de la función pulmonar progresa incluso después del cese de la exposición.
  • El diagnóstico requiere exposición ocupacional documentada y características radiológicas características, excluyendo otras condiciones.

Conclusiones:

  • La silicosis requiere un manejo integral para mejorar la calidad de vida del paciente y retrasar la progresión de la enfermedad.
  • Los riesgos asociados incluyen enfermedades micobacterianas, obstrucción de las vías respiratorias y cáncer de pulmón.
  • Los esfuerzos globales intensificados son cruciales para el control de los peligros de sílice, especialmente en los países en desarrollo.